BIRC5 and cancer: Therefore, from a cancer prevention and therapeutics point of view, the idea that survivin-2B may act as a natural antagonist against the function of survivin and/or survivin-ΔEx3 may lead to novel approaches for cancer prevention and/or therapeutics through differential modulation of the expression of survivin and/or its variants.